212 related articles for article (PubMed ID: 35474867)
1. Discovery and validation of human genomic safe harbor sites for gene and cell therapies.
Aznauryan E; Yermanos A; Kinzina E; Devaux A; Kapetanovic E; Milanova D; Church GM; Reddy ST
Cell Rep Methods; 2022 Jan; 2(1):100154. PubMed ID: 35474867
[TBL] [Abstract][Full Text] [Related]
2. New Human Chromosomal Sites with "Safe Harbor" Potential for Targeted Transgene Insertion.
Pellenz S; Phelps M; Tang W; Hovde BT; Sinit RB; Fu W; Li H; Chen E; Monnat RJ
Hum Gene Ther; 2019 Jul; 30(7):814-828. PubMed ID: 30793977
[TBL] [Abstract][Full Text] [Related]
3. Genomics and epigenetics guided identification of tissue-specific genomic safe harbors.
Shrestha D; Bag A; Wu R; Zhang Y; Tang X; Qi Q; Xing J; Cheng Y
Genome Biol; 2022 Sep; 23(1):199. PubMed ID: 36131352
[TBL] [Abstract][Full Text] [Related]
4. Systematic identification of safe harbor regions in the CHO genome through a comprehensive epigenome analysis.
Hilliard W; Lee KH
Biotechnol Bioeng; 2021 Feb; 118(2):659-675. PubMed ID: 33049068
[TBL] [Abstract][Full Text] [Related]
5. A non-viral genome editing platform for site-specific insertion of large transgenes.
Chaudhari N; Rickard AM; Roy S; Dröge P; Makhija H
Stem Cell Res Ther; 2020 Sep; 11(1):380. PubMed ID: 32883366
[TBL] [Abstract][Full Text] [Related]
6. Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies.
Dabiri H; Safarzadeh Kozani P; Habibi Anbouhi M; Mirzaee Godarzee M; Haddadi MH; Basiri M; Ziaei V; Sadeghizadeh M; Hajizadeh Saffar E
Biomark Res; 2023 Jul; 11(1):67. PubMed ID: 37403182
[TBL] [Abstract][Full Text] [Related]
7. Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.
Scholler J; Brady TL; Binder-Scholl G; Hwang WT; Plesa G; Hege KM; Vogel AN; Kalos M; Riley JL; Deeks SG; Mitsuyasu RT; Bernstein WB; Aronson NE; Levine BL; Bushman FD; June CH
Sci Transl Med; 2012 May; 4(132):132ra53. PubMed ID: 22553251
[TBL] [Abstract][Full Text] [Related]
8. A system for site-specific integration of transgenes in mammalian cells.
Chi X; Zheng Q; Jiang R; Chen-Tsai RY; Kong LJ
PLoS One; 2019; 14(7):e0219842. PubMed ID: 31344144
[TBL] [Abstract][Full Text] [Related]
9. Safe genetic modification of cardiac stem cells using a site-specific integration technique.
Lan F; Liu J; Narsinh KH; Hu S; Han L; Lee AS; Karow M; Nguyen PK; Nag D; Calos MP; Robbins RC; Wu JC
Circulation; 2012 Sep; 126(11 Suppl 1):S20-8. PubMed ID: 22965984
[TBL] [Abstract][Full Text] [Related]
10. Generation of stable cell lines by site-specific integration of transgenes into engineered Chinese hamster ovary strains using an FLP-FRT system.
Zhou H; Liu ZG; Sun ZW; Huang Y; Yu WY
J Biotechnol; 2010 May; 147(2):122-9. PubMed ID: 20371256
[TBL] [Abstract][Full Text] [Related]
11. Optimizing viral and non-viral gene transfer methods for genetic modification of porcine mesenchymal stem cells.
Stiehler M; Duch M; Mygind T; Li H; Ulrich-Vinther M; Modin C; Baatrup A; Lind M; Pedersen FS; Bünger CE
Adv Exp Med Biol; 2006; 585():31-48. PubMed ID: 17120775
[TBL] [Abstract][Full Text] [Related]
12. Screen and Verification for Transgene Integration Sites in Pigs.
Ma L; Wang Y; Wang H; Hu Y; Chen J; Tan T; Hu M; Liu X; Zhang R; Xing Y; Zhao Y; Hu X; Li N
Sci Rep; 2018 May; 8(1):7433. PubMed ID: 29743638
[TBL] [Abstract][Full Text] [Related]
13. Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome.
DeKelver RC; Choi VM; Moehle EA; Paschon DE; Hockemeyer D; Meijsing SH; Sancak Y; Cui X; Steine EJ; Miller JC; Tam P; Bartsevich VV; Meng X; Rupniewski I; Gopalan SM; Sun HC; Pitz KJ; Rock JM; Zhang L; Davis GD; Rebar EJ; Cheeseman IM; Yamamoto KR; Sabatini DM; Jaenisch R; Gregory PD; Urnov FD
Genome Res; 2010 Aug; 20(8):1133-42. PubMed ID: 20508142
[TBL] [Abstract][Full Text] [Related]
14. Integrative genome comparison of primary and metastatic melanomas.
Kabbarah O; Nogueira C; Feng B; Nazarian RM; Bosenberg M; Wu M; Scott KL; Kwong LN; Xiao Y; Cordon-Cardo C; Granter SR; Ramaswamy S; Golub T; Duncan LM; Wagner SN; Brennan C; Chin L
PLoS One; 2010 May; 5(5):e10770. PubMed ID: 20520718
[TBL] [Abstract][Full Text] [Related]
15. Towards safe, non-viral therapeutic gene expression in humans.
Glover DJ; Lipps HJ; Jans DA
Nat Rev Genet; 2005 Apr; 6(4):299-310. PubMed ID: 15761468
[TBL] [Abstract][Full Text] [Related]
16. Delivery and long-term expression of a 135 kb LDLR genomic DNA locus in vivo by hydrodynamic tail vein injection.
Hibbitt OC; Harbottle RP; Waddington SN; Bursill CA; Coutelle C; Channon KM; Wade-Martins R
J Gene Med; 2007 Jun; 9(6):488-97. PubMed ID: 17471590
[TBL] [Abstract][Full Text] [Related]
17. piggyBac transposon system modification of primary human T cells.
Saha S; Nakazawa Y; Huye LE; Doherty JE; Galvan DL; Rooney CM; Wilson MH
J Vis Exp; 2012 Nov; (69):e4235. PubMed ID: 23149543
[TBL] [Abstract][Full Text] [Related]
18. Nonviral gene delivery with the sleeping beauty transposon system.
Ivics Z; Izsvák Z
Hum Gene Ther; 2011 Sep; 22(9):1043-51. PubMed ID: 21867398
[TBL] [Abstract][Full Text] [Related]
19. Wide Awake and Ready to Move: 20 Years of Non-Viral Therapeutic Genome Engineering with the Sleeping Beauty Transposon System.
Hodge R; Narayanavari SA; Izsvák Z; Ivics Z
Hum Gene Ther; 2017 Oct; 28(10):842-855. PubMed ID: 28870121
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
